Momenta Pharmaceuticals, Inc. (MNTA)

[Mpower]

Share price has been pathetic. It is really disappointing. Management has been very quiet. While scientists have been doing a phenonemal job, only thing management knows how to do is sell their shares and have UBS dilute shareholders.

Franky speaking, this is probably one of the worst post approval (blockbuster) scenarios I have seen in the history of biotech. Suffice it to say, a ignorant derelict could do a better job than Wheeler et. all at communicating the MNTA story to the market.